- Product Details
Keywords
- 211915-84-3 seller
- 211915-84-3 supplier
- 211915-84-3 manufacturer
Quick Details
- ProName: 3-[[[2-[[(4-Cyanophenyl)amino]methyl]-...
- CasNo: 211915-84-3
- Molecular Formula: C27H26N6O3
- Application: Dabigatran Etexilate intermediate
- Port: shanghai;hangzhou
- ProductionCapacity: Metric Ton/Day
- Transportation: by sea; by air
- LimitNum: 0 Metric Ton
Superiority
Anhui Qingyun Pharmaceutical and Chemical Co.,Ltd
Our total assets: 4 million yuan
Total area: 15 acres, including 2500sq.m workshop
We are specialized in R&D; manufactuing and marketing of fine chemical; medical protomer and intermediate integrates.
We invest 15% of annual production value expenses into R&D every year, for the corporation speediness and exuberance development.
Details
Year Establishment: 2003
Location:We are located in Luyang Science Technology Development Zone
Main Products: Rosuvastatin calcium & intermediate; Pitavastatin calcium & intermediate; Betaxolol & intermediate; Amlexanox & intermediate; Ranolazine & intermediate; Proparacaine hydrochloride & intermediate; Silodosin & intermediate; Rotigotine & intermediates;Febuxostat & intermediate;Erdosteine&intermediate; Amtolmetin guacil; Calcium levofolinate;Almotriptar
Specifications:
Name 3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester
Molecular Formula C27H26N6O3
Molecular Weight 482.53
CAS Registry Number 211915-84-3
Uses Dabigatran Etexilate intermediate
Our factory: